Core Insights - Index funds have significantly outperformed active equity funds in 2023, with many achieving year-to-date returns exceeding 90%, even approaching 100% [1][2] - The performance gap is particularly notable among large public funds, where index funds have outperformed their actively managed counterparts, highlighting the limitations of active fund managers in extreme market conditions [1][3] Performance Comparison - Several index products, such as the GF Hong Kong Innovation Drug ETF and the Huatai-PineBridge National Innovation Drug ETF, have achieved returns of over 90% and 95% as of August 1, 2023, outperforming 90% of active equity products [3][4] - For instance, the GF Hong Kong Innovation Drug ETF has a return of 95%, while its actively managed counterpart, the GF Shanghai-Hong Kong-Shenzhen Pharmaceutical Fund, has a return of 79% [3][4] - The Tianhong Hong Kong-Shenzhen Innovation Drug ETF has a return of 51%, compared to 34% for the Tianhong Healthcare Fund [3][4] Market Dynamics - The extreme performance of index products is closely linked to the current market conditions, particularly in the innovative pharmaceutical sector, where index funds can fully capitalize on their stock positions [6][7] - Active equity funds often fail to maintain full exposure to the pharmaceutical sector, limiting their performance compared to index funds that have clear and transparent allocations [6][7] Transparency and Strategy - Index products benefit from mandatory regulations regarding their holdings, leading to greater transparency compared to the flexibility afforded to active fund managers, which can result in unpredictable portfolio compositions [5][7] - The shift in focus among active fund managers, such as moving from "medical" to "innovative drugs," has led to underperformance as they struggle to adapt to market trends [8] Industry Trends - The rise of index funds is becoming a key strategy for public funds to reduce costs and reliance on star fund managers, with over 90% of new equity fund launches in 2023 being index products [10] - The integration of AI technology in asset management is expected to further enhance the efficiency of index funds, allowing for better analysis and personalized index product offerings [10]
ETF“跑赢”明星基金经理,多只指数基金收益率超90
Zheng Quan Shi Bao·2025-08-03 12:56